Interleukin-2 and interleukin-4 display potent antitumour activity on rat medullary thyroid carcinoma cells

This publication has 12 references indexed in Scilit:

• A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
  Science, 1991
• Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4
  Science, 1991
• rIL-4 differentially regulates rIL-2-induced murine NK and LAK killing in CD8⁺ and CD8⁻precursor cell subsets
  International Immunology, 1991
• Interleukin 2‐dependent activation of tumor‐specific cytotoxic T lymphocytes in vivo
  European Journal of Immunology, 1991
• Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.
  The Journal of Experimental Medicine, 1990
• Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
  Cell, 1990
• Murine interleukin-4 displays potent anti-tumor activity in vivo
  Cell, 1989
• Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors
  European Journal of Immunology, 1988
• Cancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated Lymphocytes
  Annual Review of Immunology, 1986
• Familial Amyloid-producing Medullary Thyroid Carcinoma and Pheochromocytoma
  Annals of Internal Medicine, 1965